Dark

CBIO
Crescent Biopharma, Inc. Common Stock
stock NASDAQ

At Close

Jun 27, 2025 3:59:30 PM EDT

16.00USD-5.325%(-0.90)54,069

0.00Bid 0.00Ask 0.00Spread

Pre-market

Jun 27, 2025 8:17:30 AM EDT

16.89USD-0.059%(-0.01)302

After-hours

Jun 25, 2025 4:26:30 PM EDT

18.48USD+1.260%(+0.23)0

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

310.25M

CEO

Nassim Usman

Headquarters

South San Francisco, California, USA

Industry

Biotechnology

Last Dividend

Aug 20, 20151.649

Last Split

Jun 16, 20251for100reverse

CORT AZN BMY JNJ PFE MRK ABBV ADMS ZGNX XLV

CBIO Stats

Avg. Vol. 10 Day

50,253

Avg. Vol. 30 Day

32,615

Employees

Market Cap

310,245,000

Shares Out.

19,500,000

On/Off Exchange

41%/59%

6 Month Beta

1.84

1 Year Beta

18.54

2 Year Beta

0.91

3 Year Beta

0.43

52 Week Low

7.20

52 Week High

21.40

SMA50

8.55

SMA200

5.38

1 Week

+6.07%

1 Month

+0.73%

1 Year

+107.45%

2 Year

+224.56%

5 Year

-82.02%

Profile

catalyst is focused on developing novel medicines to address serious medical conditions for patients who need new or better treatment options. we used a scientific approach focused on protease-based therapeutic candidates to build a clinical-stage biopharmaceutical company whose current mission is to develop valuable therapies for patients with hemophilia. learn more about our hemophilia program. a protease is an enzyme that cleaves target proteins. learn more about proteases.

CBIO Stock Summary

Crescent Biopharma, Inc. Common Stock (NASDAQ:CBIO) stock price today is $16.00, and today's volume is 54,069. CBIO is down -5.325% today. The 30 day average volume is 32,615. CBIO market cap is 310.25M with 19,500,000 shares outstanding.